Trendlines Group must show it can build great companies
Stock price has been languishing either because of insufficient understanding of its business or poor public investor appetite for incubators
THE Trendlines Group, an Israel-based medtech incubator listed on the Singapore Exchange (SGX), has received a shot in the arm of up to S$2.2 million from Spring Singapore.
The grant that its subsidiary Trendlines Medical Singapore will receive from the enterprise development agency of the Singapore Ministry of Trade and Industry is for the unit to invest in and nurture medical technology (medtech) startups. It comes under the Incubator Development Programme.
But while the financing - the first that the group is receiving from the agency just more than a year after…
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
China to facilitate Hong Kong IPOs and expand Stock Connect
Global equity funds see surge in outflows as rate cut hopes fade
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
Global wave of consultancy layoffs has not hit Singapore
P&G raises annual core profit forecast on resilient demand, price hikes
American Express’ premium customers help it surpass profit expectations